THYROCAREThyrocare Technologies Limited
Healthcare · Diagnostics & Research · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹557.95
▲ 7.17%Excellent
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)8,601.90
P/E52.93
P/B16.08
PEG0.46
ROE %28.75
ROCE %32.20
Debt / Equity0.09
EPS10.21
Revenue Growth %19.70
Profit Growth %116.30
Dividend Yield %3.08
Promoter Holding %61.09
FII Holding %21.47
DII Holding %—
Beta0.47
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 75% | ₹557.95 | ₹505.50 | ₹627.35 | 1.32 |
| EMA Crossover | LONG | 71% | ₹557.95 | ₹505.50 | ₹662.85 | 2.00 |
BUYConviction 88%
Why buy
- • Revenue growth: 19.7% YoY
- • Profit growth: 116.3% YoY
- • ROE: 28.8%
- • RSI: 59
- • Price vs EMA21: above
- • Price vs SMA50: above
- • EMA Crossover signal (setup quality 71%)
- • Pullback to 21-EMA signal (setup quality 75%)
Bull case
- • Revenue growth: 19.7% YoY
- • Profit growth: 116.3% YoY
- • ROE: 28.8%
- • RSI: 59
Bear case
- • MACD: bearish
- • Volume trend: 0.8x baseline
- • Max drawdown (1y): 34%
Key risks
- • MACD: bearish
- • Volume trend: 0.8x baseline
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹557.95
Stop Loss
₹500.44
risk 10.3%
Target 1 (1.5R)
₹644.21
+15.5%
Target 2 (3R)
₹730.47
+30.9%
Support (20d)
₹505.50
Resistance (52w)
₹574.90
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹57.51/share
ATR (volatility)
₹23.56
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹23.56). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
94
Technical
78
Momentum
79
Risk (safety)
58